FDA accepted the supplemental New Drug Application for Cresemba (isavuconazonium sulfate), a prodrug of isavuconazole, an azole antifungal drug, seeking approval for the treatment of invasive aspergillosis or invasive mucormycosis in pediatric patients aged one to 17 years old.Â
Setting cancer drug dosage used to be easy: find the delicate balance between killing the disease and subjecting the patient to intolerable harm, and you are done.
Seven scientists will be awarded $600,000 in grants dedicated to osteosarcoma research from MIB Agents, a pediatric osteosarcoma nonprofit. The scientists will be presented their grants at the MIB Agents’ FACTOR Conference in Atlanta, Georgia, this June.
The Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital established a pediatric-focused fellowship which aims to help address the critical shortage of top young scientists who often seek more prevalent opportunities in adult cancer research or the pharmaceutical sector. The Damon Runyon—St. Jude Pediatric Cancer Research Fellowship will fund up to 25 fellowships over eight years, a $9 million investment.
Virginia Tech researchers with the Fralin Biomedical Research Institute at VTC have joined a Children’s National Hospital effort to treat deadly brain tumors with ultrahigh frequency sound waves.
Michael Taylor was named director of the Pediatric Neuro-Oncology Research Program at Texas Children’s Hospital and at Baylor College of Medicine.
FLAG-003, an investigational small molecule therapy developed by FLAG Therapeutics Inc. for the treatment of diffuse intrinsic pontine glioma—a rare, highly aggressive and difficult to treat brain tumor found in children—has been granted Rare Pediatric Disease designation from FDA.
Cancer Research UK, The University of Manchester, and Roche Products Ltd. opened a multi-drug, precision medicine trial for people with rare cancers who need more treatment options. The trial is set up to recruit both pediatric and adult patients with any rare cancer type.
Martha Donoghue was named associate director of pediatric oncology and rare cancers in the FDA Oncology Center of Excellence.Â
Oksana Leontyeva, an expert in hematologic malignancies, was killed in a Russian rocket attack as she was rushing through central Kyiv to take care of her patients at OKHMATDYT, the biggest children’s hospital in Ukraine.
